Price To Earnings Ratio 44.23 | Sector PE 63.19 |
PB Ratio 6.72 | Sector PB 8.18 |
EPS 28.82 | Dividend Yield 0.00 |
Today's Volume 35.169 K | 5 Day Avg. Volume 451.645 K |
PEG Ratio 17.41 | Market Cap. ₹ 18,940.00 Cr. |
Eris Lifesciences Limited is an Indian company primarily engaged in the production and distribution of pharmaceutical products. The company's manufacturing facility is located in Guwahati, Assam. Its therapeutic areas include oral diabetes, cardiac, pain/analgesic, gynecology, gastrointestinal, central nervous system (CNS) and vitamins, minerals and nutrients (VMN). The company's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cybex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The company's 100% subsidiaries are Kinedex Healthcare Private Limited, Aprica Healthcare Limited and Eris Healthcare Private Limited.